Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19
Clinical trial NCT04412668 · COMPLETED
Trial details
- NCT number
- NCT04412668
- Sponsor
- aTyr Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-04
- Primary completion
- 2020-10-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.